---
schema_version: "secwatch.filing_event.v1"
accession: "0001824293-22-000007"
form_type: "8-K"
ticker: "GRI"
cik: "0001824293"
company_name: "GRI Bio, Inc."
filed_at: "2022-02-28T23:59:59+00:00"
generated_at: "2026-06-27T03:49:42.001405+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Vallon Pharmaceuticals adds Meenu Karson to board; Ofir Levi steps down from committees

## Summary
- Board expanded from 5 to 6 directors; Meenu Karson appointed as independent director.
- Ofir Levi resigned from Audit and Nominating & Corporate Governance committees but remains Board Chair.
- Karson appointed to Audit Committee and as Chair of Nominating & Corporate Governance Committee.
- Karson is former President/CEO of Proteostasis Therapeutics, raised $300M+ and led IPO.

## SEC filing metadata
- accession: 0001824293-22-000007
- form_type: 8-K
- ticker: GRI
- cik: 0001824293
- company_name: GRI Bio, Inc.
- filed_at: 2022-02-28T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1824293/000182429322000007/0001824293-22-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1824293/000182429322000007/ck00018242493-20220223.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001824293-22-000007
- JSON: https://secwatch.observer/filing/0001824293-22-000007.json
- Plain text: https://secwatch.observer/filing/0001824293-22-000007.txt

## Key facts
- Executive change
  Meenu Karson was appointed as director at GRI Bio, Inc..
  - Action: appointed
  - Role: director
  source text: increased the size of the Board from five directors to six directors and appointed Meenu Karson to serve as a member of the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1824293/000182429322000007/0001824293-22-000007-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.